|
Volumn 11, Issue 2, 2006, Pages 118-119
|
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOZAPINE;
IODINE DERIVATIVE;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NEUROLEPTIC AGENT;
TRACER;
AGE DISTRIBUTION;
ANALYSIS OF VARIANCE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE DURATION;
HIPPOCAMPUS;
HUMAN;
IN VIVO STUDY;
LETTER;
POSITIVE AND NEGATIVE SYNDROME SCALE;
PRIORITY JOURNAL;
RECEPTOR BINDING;
SCHIZOPHRENIA;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
STATISTICAL PARAMETERS;
ANALYSIS OF VARIANCE;
ANTIPSYCHOTIC AGENTS;
CASE-CONTROL STUDIES;
CLOZAPINE;
FUNCTIONAL LATERALITY;
GENETIC PREDISPOSITION TO DISEASE;
GUANIDINES;
HIPPOCAMPUS;
HUMANS;
RECEPTORS, N-METHYL-D-ASPARTATE;
REFERENCE VALUES;
SCHIZOPHRENIA;
TISSUE DISTRIBUTION;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
EID: 31544442970
PISSN: 13594184
EISSN: 14765578
Source Type: Journal
DOI: 10.1038/sj.mp.4001751 Document Type: Letter |
Times cited : (226)
|
References (7)
|